Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Luzza

Showing results (61-70 of 159) with videos related to

Pageof 16
Sort By:
Panminerva Medica|June 2, 2018
Hepatitis C virus-induced hepatocellular carcinoma: a narrative reviewMaja Ružić, Rinaldo Pellicano, Milotka Fabri, et al.
Minerva Medica|May 14, 2019
Noninvasive assessment of liver fibrosis in chronic hepatitis C virus patients compared to liver biopsy: the experience of tertiary level hospital in SerbiaTomislav Preveden, Benjamin Vereš, Maja Ružić, et al.
Minerva Medica|May 18, 2022
Noninvasive biochemical markers and surrogate scores in evaluating nonalcoholic steatohepatitisAbdalla Elsayed, Abdulrahman Ismaiel, Anna C Procopio, et al.
Medicina (Kaunas, Lithuania)|November 25, 2023
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional StudyLudovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, et al.
Minerva Gastroenterology|May 5, 2022
Treatment with phosphatidylcholine of patients with nonalcoholic fatty liver disease: a prospective pilot studyLudovico Abenavoli, Roman Myazin, Sharmila Fagoonee, et al.
Reviews on Recent Clinical Trials|September 25, 2025
Microscopic Colitis and Gut Microbiota: A Narrative ReviewCarmen Colaci, Giuseppe Guido Maria Scarlata, Alessandro Corea, et al.
Molecular Biology Reports|September 5, 2020
The protective effects of resveratrol on ulcerative colitis via changing the profile of Nrf2 and IL-1β proteinMilad Sabzevary-Ghahfarokhi, Amin Soltani, Francesco Luzza, et al.
Diseases (Basel, Switzerland)|June 14, 2020
Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor AgonistsLudovico Abenavoli, Anna Caterina Procopio, Sharmila Fagoonee, et al.
Reviews on Recent Clinical Trials|February 25, 2020
Barriers and Facilitators in Conducting Clinical Trials in Inflammatory Bowel Disease: A Monocentric Italian SurveyTiziana Larussa, Evelina Suraci, Raffaella Marasco, et al.
Medicina (Kaunas, Lithuania)|April 27, 2024
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota TransplantationLudovico Abenavoli, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, et al.
Pageof 16

Showing results (61-70 of 159) with videos related to

Sort By:
Pageof 16
Panminerva Medica|June 2, 2018
Hepatitis C virus-induced hepatocellular carcinoma: a narrative reviewMaja Ružić, Rinaldo Pellicano, Milotka Fabri, et al.
Minerva Medica|May 14, 2019
Noninvasive assessment of liver fibrosis in chronic hepatitis C virus patients compared to liver biopsy: the experience of tertiary level hospital in SerbiaTomislav Preveden, Benjamin Vereš, Maja Ružić, et al.
Minerva Medica|May 18, 2022
Noninvasive biochemical markers and surrogate scores in evaluating nonalcoholic steatohepatitisAbdalla Elsayed, Abdulrahman Ismaiel, Anna C Procopio, et al.
Medicina (Kaunas, Lithuania)|November 25, 2023
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional StudyLudovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, et al.
Minerva Gastroenterology|May 5, 2022
Treatment with phosphatidylcholine of patients with nonalcoholic fatty liver disease: a prospective pilot studyLudovico Abenavoli, Roman Myazin, Sharmila Fagoonee, et al.
Reviews on Recent Clinical Trials|September 25, 2025
Microscopic Colitis and Gut Microbiota: A Narrative ReviewCarmen Colaci, Giuseppe Guido Maria Scarlata, Alessandro Corea, et al.
Molecular Biology Reports|September 5, 2020
The protective effects of resveratrol on ulcerative colitis via changing the profile of Nrf2 and IL-1β proteinMilad Sabzevary-Ghahfarokhi, Amin Soltani, Francesco Luzza, et al.
Diseases (Basel, Switzerland)|June 14, 2020
Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor AgonistsLudovico Abenavoli, Anna Caterina Procopio, Sharmila Fagoonee, et al.
Reviews on Recent Clinical Trials|February 25, 2020
Barriers and Facilitators in Conducting Clinical Trials in Inflammatory Bowel Disease: A Monocentric Italian SurveyTiziana Larussa, Evelina Suraci, Raffaella Marasco, et al.
Medicina (Kaunas, Lithuania)|April 27, 2024
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota TransplantationLudovico Abenavoli, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, et al.
Pageof 16